DrugPatentWatch Database Preview
Taro Pharm Inds Ltd Company Profile
What is the competitive landscape for TARO PHARM INDS LTD, and what generic alternatives to TARO PHARM INDS LTD drugs are available?
TARO PHARM INDS LTD has twenty-one approved drugs.
There are two US patents protecting TARO PHARM INDS LTD drugs. There are two tentative approvals on TARO PHARM INDS LTD drugs.
There are ten patent family members on TARO PHARM INDS LTD drugs in seven countries and ten supplementary protection certificates in five countries.
Summary for Taro Pharm Inds Ltd
| International Patents: | 10 |
| US Patents: | 2 |
| Tradenames: | 13 |
| Ingredients: | 11 |
| NDAs: | 21 |
Drugs and US Patents for Taro Pharm Inds Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taro Pharm Inds Ltd | TOPICORT | desoximetasone | GEL;TOPICAL | 074904-001 | Jul 14, 1998 | AB | RX | No | Yes | Start Trial | Start Trial | ||||
| Taro Pharm Inds Ltd | ILOPERIDONE | iloperidone | TABLET;ORAL | 207098-007 | Jul 22, 2019 | DISCN | No | No | Start Trial | Start Trial | |||||
| Taro Pharm Inds Ltd | ACETAMINOPHEN | acetaminophen | SUPPOSITORY;RECTAL | 018337-003 | Sep 12, 1983 | OTC | Yes | No | Start Trial | Start Trial | |||||
| Taro Pharm Inds Ltd | TOPICORT | desoximetasone | CREAM;TOPICAL | 073193-001 | Nov 30, 1990 | AB | RX | No | Yes | Start Trial | Start Trial | ||||
| Taro Pharm Inds Ltd | DEFERIPRONE | deferiprone | TABLET;ORAL | 208800-001 | Feb 8, 2019 | DISCN | No | No | Start Trial | Start Trial | |||||
| Taro Pharm Inds Ltd | FLUOCINONIDE EMULSIFIED BASE | fluocinonide | CREAM;TOPICAL | 072494-001 | Jan 19, 1989 | AB2 | RX | No | Yes | Start Trial | Start Trial | ||||
| Taro Pharm Inds Ltd | TOPICORT | desoximetasone | GEL;TOPICAL | 018586-001 | Mar 29, 1982 | DISCN | Yes | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for TARO PHARM INDS LTD drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Topical Spray | 0.25% | ➤ Subscribe | 2013-12-18 |
| ➤ Subscribe | Topical Lotion | 0.5% | ➤ Subscribe | 2011-03-16 |
International Patents for Taro Pharm Inds Ltd Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2009500422 | Start Trial |
| China | 103087095 | Start Trial |
| Brazil | PI0612686 | Start Trial |
| Japan | 2013032405 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2007005988 | Start Trial |
| Japan | 5474347 | Start Trial |
| China | 101287374 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Taro Pharm Inds Ltd Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0663828 | C300085 | Netherlands | Start Trial | PRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103 |
| 0809498 | 10C0038 | France | Start Trial | PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026 |
| 1110543 | 08C0004 | France | Start Trial | PRODUCT NAME: DESLORATADINE; PSEUDOEPHEDRINE SULFATE; REGISTRATION NO/DATE: EU/1/07/399/001 20070730 |
| 1586316 | C 2011 004 | Romania | Start Trial | PRODUCT NAME: BROMFENAC, SARURILE SI HIDRATII SAI ACCEPTABILI FARMACEUTICACID 2-[2-AMINO-3-(4-BROMOBENZOIL)FENILACETIC; NATIONAL AUTHORISATION NUMBER: RO EU/1/11/692/001; DATE OF NATIONAL AUTHORISATION: 20110518; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EMEA EU/1/11/692/001; DATE OF FIRST AUTHORISATION IN EEA: 20110518 |
| 0152897 | 2001C/013 | Belgium | Start Trial | PRODUCT NAME: DESLORATADINE; REGISTRTION NO/DATE: EU/1/00/160/010 20010115 |
| 0152897 | SPC/GB01/012 | United Kingdom | Start Trial | PRODUCT NAME: DESLORATADINE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/00/157/001-013 20010115; UK EU/1/00/158/001-013 20010115; UK EU/1/00/159/001-013 20010115; UK EU/1/00/160/001-013 20010115; UK EU/1/00/161/001-013 20010115 |
| 1110543 | SPC/GB08/005 | United Kingdom | Start Trial | SUPPLEMENTARY PROTECTION CERTIFICATE NO SPC/GB08/005 GRANTED TO MERCK SHARP + DOHME CORP. IN RESPECT OF THE PRODUCT DESLORATADINE OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, IN COMBINATION WITH PSEUDOEPHEDRINE OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT OR ESTER, THE GRANT OF WHICH WAS ADVERTISED IN JOURNAL NO 6322 DATED 21 JULY 2010 HAS HAD ITS MAXIMUM PERIOD OF DURATION CORRECTED, SUBJECT TO THE PAYMENT OF THE PRESCRIBED FEES IT WILL EXPIRE ON 31 JULY 2022. |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
